Neurology

OxyContin Maker Explored Expansion Into Anti-Addiction Market






Secret portions of a lawsuit allege that Purdue Pharma considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its controversial opioid.
ProPublica

Source link




Related posts

What are the 10 most eminently curable neurological disorders?

Newsemia

Long-term Lamotrigine, Levetiracetam Comparable to Brand Name Drugs in Epilepsy

Newsemia

Author response: Personalizing acute therapies for ischemic stroke: Thrombolysis or thrombectomy?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy